Le Lézard
Classified in: Health
Subjects: NPT, CHI, HSP, VET, DIS

Christopher & Dana Reeve Foundation releases new edition of Paralysis Resource Guide


SHORT HILLS, N.J., Oct. 10, 2017 /PRNewswire-USNewswire/ -- The Christopher & Dana Reeve Foundation, a national nonprofit dedicated to improving quality of life for individuals living with paralysis, is pleased to announce the release of its newly updated Paralysis Resource Guide (PRG) from the Foundation's Paralysis Resource Center (PRC). Since 2002, when the PRC was first established, the Foundation has distributed over 200,000 copies of the PRG to people living with paralysis, their caregivers and family members.

Christopher & Dana Reeve Foundation. (PRNewsFoto/Christopher & Dana Reeve Foundation)

The 4th edition of the PRG has up to date paralysis-related information, topics on secondary conditions (pain, spasticity, etc.), travel, employment, disability benefits, and sports and recreation. There are entire sections devoted to caregivers, military and veterans and children living with paralysis. A new Profile section features individual stories from people and families impacted by the PRC's programs and resources such as Information Specialists, the Peer & Family Support Program, Military and Veterans Program (MVP), Quality of Life Grant Program and the NeuroRecovery Network.

In this updated edition, the PRG features a revamped chapter (Chapter 6) on the latest tools and technology including assistive technology, home modifications, wheelchairs, environmental controls, universal design, and driving an adapted car. Wireless connectivity is featured for the first time with sections on eye gaze technology, voice recognition, and information on new products in this area.  Other new topics include:

To order a FREE copy(ies), please call 1-800-539-7309 or 973-379-2690. To order online or view via PDF, please see www.ChristopherReeve.org/Guide, or you can email us at [email protected]. The PRG is also available on a flash drive if requested. ISBN 978-0-9960951-5-0

Look out for the Spanish version of the Paralysis Resource Guide in the Summer of 2018.

About the Reeve Foundation:

The Christopher & Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research and improving the quality of life for people living with paralysis through grants, information and advocacy. We meet all 20 of the Better Business Bureau's standards for charity accountability and hold the BBB's Charity Seal. The Paralysis Resource Center (PRC) is a program of the Reeve Foundation and is funded through a cooperative agreement with the Administration for Community Living (cooperative agreement number 90PR3002). For more information, please visit our website at www.ChristopherReeve.org or call 800-539-7309.

 

SOURCE Christopher & Dana Reeve Foundation


These press releases may also interest you

at 01:10
HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that HAYA's Co-Founders Samir Ounzain and Daniel Blessing have received the inaugural Andreas & Thomas...

at 01:05
The committee of the newly established Andreas & Thomas Struengmann Award today announced that Samir Ounzain and Daniel Blessing, the two co-founders of HAYA Therapeutics, are the inaugural winners of the Andreas & Thomas Struengmann Award....

at 01:05
ReCerise Therapeutics Inc. (CEO Yong-Bae Kim), has announced its selection for a grant from the Ministry of Trade, Industry and Energy (MOTIE) of South Korea. The grant aims to support the development of tailored targeted therapies for refractory...

at 01:00
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules FDA approves biosimilar PyzchivaŽ (ustekinumab-ttwe), to be commercialized by Sandoz in US PyzchivaŽ (ustekinumab-ttwe) is approved by FDA for all indications of reference...

at 01:00
Education Cannot Wait (ECW) and the Aga Khan Foundation (AKF) announce an expanded three-year partnership that will improve holistic quality learning outcomes and quality learning environments for crisis-affected learners in Afghanistan, Pakistan and...

30 jun 2024
SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug...



News published on and distributed by: